Brain Training for Substance Use Disorders
NCT06870110 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-03-11
Summary
Participants play games designed to train visual attention towards natural, non-drug-related scenarios. A biofeedback loop between gameplay and an electroencephalogram (EEG) system monitors game performance and guides game difficulty.
Conditions
Interventions
- DEVICE
-
Bias Modification Biofeedback
The device uses EEG-based bias modification biofeedback intended to reduce attention to drug-related cues and increase attention to non-drug pleasant scenes. Specifically, the device measures perceptual biases from Event-Related Potential biomarkers related to Substance Use Disorders.
Sponsors & Collaborators
- collaborator OTHER
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Neurotype Inc.
lead INDUSTRY
Principal Investigators
-
Justin Anker, PhD · University of Minnesota
-
Scott Burwell, PhD · Neurotype Inc.
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-01-17
- Primary Completion
- 2025-08-31
- Completion
- 2025-08-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Brain Function in Response to Motivational Stimuli
NCT00047866 ·Status: COMPLETED
-
The Effect of Mindfulness-based Relapse Prevention on Impulsive Control Circuit Among Methamphetamine Dependents
NCT03748875 ·Status: UNKNOWN ·Phase: NA
-
A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication
NCT06629740 ·Status: COMPLETED ·Phase: NA
-
Acquisition of Responses to a Methamphetamine-associated Cue in Healthy Humans
NCT02323048 ·Status: COMPLETED ·Phase: NA
-
Behavior Brain Responses
NCT03964350 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PHAST: Physical Activity in Substitution Therapy
NCT02309021 ·Status: COMPLETED ·Phase: NA
-
Mobile Health Cognitive Stimulation in Heroin Users
NCT02308878 ·Status: COMPLETED ·Phase: NA
-
Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity
NCT04427709 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation
NCT01037608 ·Status: COMPLETED ·Phase: PHASE1
-
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
NCT06160284 ·Status: RECRUITING ·Phase: PHASE1
-
The Effects of Fentanyl Abuse on Executive Function and Related Brain Activity
NCT05469217 ·Status: UNKNOWN
-
A First Study in Healthy Volunteers of a New Mobile Phone Application Measuring the Eyes Before and After Medication
NCT05731999 ·Status: COMPLETED ·Phase: NA
-
Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder
NCT03143855 ·Status: COMPLETED ·Phase: PHASE1
-
Marijuana Drug Discrimination and Self-Administration
NCT00943930 ·Status: COMPLETED
-
Stanford Regulating Circuits of the Brain Study- Ketamine
NCT03475277 ·Status: COMPLETED
-
Causal Mechanisms of Odor-Guided Behavior in Humans
NCT07099092 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Developing a Mobile Method to Measure THC-induced Impairment
NCT03804840 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II
NCT02652195 ·Status: UNKNOWN ·Phase: PHASE2
-
Methamphetamine and Troriluzole
NCT06989853 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Changes in Striatal [11C]ORM-13070 Binding Elicited by Changing Levels of Endogenous Noradrenaline
NCT01794975 ·Status: COMPLETED ·Phase: PHASE1
-
Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs
NCT06815653 ·Status: RECRUITING ·Phase: PHASE1
-
Effects of MDMA on Social and Emotional Processing
NCT01849419 ·Status: COMPLETED ·Phase: NA
-
Effects of Stress and Drug-cue Exposure (SCM)
NCT03154567 ·Status: COMPLETED ·Phase: PHASE1
-
The Influence of Oxytocin on Automatic Imitation Behaviour in Healthy Adults
NCT01767025 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury
NCT03095066 ·Status: COMPLETED ·Phase: PHASE2